Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria

NCT00004397 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Porphyria

Interventions

DRUG: heme arginate
DRUG: tin mesoporphyrin

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]